Filing metadata

Accession number
0001209191-22-037029
Form type
Form 4
Filer
Kinnate Biopharma Inc.
CIK
CIK 1797768
Filed
Jun 15, 2022
Reporting period
Jun 13, 2022
Description
Insider transaction

Explore SEC Filings Hub